{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T22:36:04Z","timestamp":1790289364434,"version":"4.1.0"},"reference-count":85,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:00:00Z","timestamp":1758758400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Cancer Institute (NCI) of the National Institutes of Health","award":["U54CA233396"],"award-info":[{"award-number":["U54CA233396"]}]},{"name":"National Cancer Institute (NCI) of the National Institutes of Health","award":["U54CA233444"],"award-info":[{"award-number":["U54CA233444"]}]},{"name":"National Cancer Institute (NCI) of the National Institutes of Health","award":["U54CA233465"],"award-info":[{"award-number":["U54CA233465"]}]},{"name":"National Institutes of Health Public Access Policy"}],"content-domain":{"domain":["www.mdpi.com"],"crossmark-restriction":true},"short-container-title":["Nutrients"],"abstract":"<jats:p>Introduction: Cancer cachexia is associated with systemic inflammation and metabolic derangement, leading to muscle atrophy, which affects over 80% of pancreatic cancer patients, the highest rate among all malignancies, negatively impacting quality of life and significantly reducing survival rate. Malnutrition, skeletal muscle loss (sarcopenia), and imbalanced energy expenditure are indicators of cachexia. No established screening tools in clinical practice are specific and sensitive enough to detect pancreatic cancer in its early stages. Objective: This paper aims to provide new insights by examining contributing factors in the development of cachexia and exploring future directions for managing cachexia to improve quality of life and overall survival in patients with pancreatic cancer. Conclusions: It is clinically vital to identify nutritional risks and consider aggressive nutritional interventions as soon as pancreatic cancer is diagnosed to (1) stabilize body weight, (2) decrease the disease-associated burden, and (3) improve the quality of life. To support the clinical management of cachexia in this population, more research is needed. Specifically, research is needed to identify biomarkers, such as muscle fiber-related genes, optimize drug delivery tailored to the specific metabolic and molecular profile, combine chemotherapeutic agents with nutritional supplements, and consider non-pharmacological interventions such as acupuncture and exercise specifically for cancer-cachexia patients. A multifaceted approach will help achieve a better quality of life and prolonged overall survival in patients with pancreatic cancer.<\/jats:p>","DOI":"10.3390\/nu17193064","type":"journal-article","created":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T06:02:52Z","timestamp":1758866572000},"page":"3064","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Cachexia in Pancreatic Cancer: New Insights to Impact Quality of Life and Survival"],"prefix":"10.3390","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5669-8709","authenticated-orcid":false,"given":"Saunjoo L.","family":"Yoon","sequence":"first","affiliation":[{"name":"Department of Biobehavioral Nursing Science, College of Nursing, University of Florida, Gainesville, FL 32610, USA"},{"name":"Center for Palliative Care Research and Education (CPCRE), University of Florida, Gainesville, FL 32610, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2302-8949","authenticated-orcid":false,"given":"Oliver","family":"Grundmann","sequence":"additional","affiliation":[{"name":"College of Pharmacy, University of Florida, Gainesville, FL 32610, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherise","family":"Rogers","sequence":"additional","affiliation":[{"name":"Logrreta Cancer Center, Brown University, Providence, RI 02903, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3754-6176","authenticated-orcid":false,"given":"Judith M.","family":"Schlaeger","sequence":"additional","affiliation":[{"name":"Department of Human Development Nursing Science, College of Nursing, University of Illinois Chicago, Chicago, IL 60612, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1458-4265","authenticated-orcid":false,"given":"Bo","family":"Han","sequence":"additional","affiliation":[{"name":"Departments of Surgery and Biomedical Engineering, University of Southern California, Los Angeles, CA 90089, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Agyare","sequence":"additional","affiliation":[{"name":"College of Pharmacy and Pharmaceutical Sciences, Florida A&M University, Tallahassee, FL 32301, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3954-8933","authenticated-orcid":false,"given":"Diana J.","family":"Wilkie","sequence":"additional","affiliation":[{"name":"Department of Biobehavioral Nursing Science, College of Nursing, University of Florida, Gainesville, FL 32610, USA"},{"name":"Center for Palliative Care Research and Education (CPCRE), University of Florida, Gainesville, FL 32610, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,9,25]]},"reference":[{"key":"ref_1","first-page":"10","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1158\/0008-5472.CAN-14-0155","article-title":"Projecting cancer incidence and deaths to 2030: The unexpected burden of thyroid, liver, and pancreas cancers in the United States","volume":"74","author":"Rahib","year":"2014","journal-title":"Cancer Res."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"102196","DOI":"10.1016\/j.canep.2022.102196","article-title":"World-wide trends in net survival from pancreatic cancer by morphological sub-type: An analysis of 1,258,329 adults diagnosed in 58 countries during 2000\u20132014 (CONCORD-3)","volume":"80","author":"Matz","year":"2022","journal-title":"Cancer Epidemiol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s12032-022-01764-2","article-title":"Pancreatic adenocarcinoma and pancreatic high-grade neuroendocrine carcinoma: Two sides of the moon","volume":"39","author":"Persano","year":"2022","journal-title":"Med. Oncol."},{"key":"ref_5","unstructured":"National Cancer Institute (2024, November 05). Pancreatic Neuroendocrine Tumors (Islet Cell Tumors) Treatment (PDQ\u00ae)\u2013Health Professional Version, Available online: www.cancer.gov\/types\/pancreatic\/hp\/pnet-treatment-pdq."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1053\/j.gastro.2020.02.068","article-title":"Global Burden of 5 major types of gastrointestinal cancer","volume":"159","author":"Arnold","year":"2020","journal-title":"Gastroenterology"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1177\/153303460500400309","article-title":"Pancreatic cancer epidemiology","volume":"4","author":"Verma","year":"2005","journal-title":"Technol. Cancer Res. Treat."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.hoc.2022.07.002","article-title":"Pancreatic adenocarcinoma: Trends in epidemiology, risk factors, and outcomes","volume":"36","author":"Afghani","year":"2022","journal-title":"Hematol. Clin. N. Am."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Grinstead, C., and Yoon, S.L. (2025). Geriatric Nutritional Risk Index (GNRI) and survival in pancreatic cancer: A retrospective study. Nutrients, 17.","DOI":"10.3390\/nu17030509"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Grinstead, C., George, T., Han, B., and Yoon, S.L. (2022). Associations of overall survival with Geriatric Nutritional Risk Index in patients with advanced pancreatic cancer. Nutrients, 14.","DOI":"10.3390\/nu14183800"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1002\/jcsm.12398","article-title":"Predicting unintentional weight loss in patients with gastrointestinal cancer","volume":"10","author":"Yoon","year":"2019","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Dionyssiotis, Y. (2017). Pancreatic cancer cachexia: Current concepts and clinical management. Frailty and Sarcopenia\u2014Onset, Development and Clinical Challenges, IntechOpen.","DOI":"10.5772\/65153"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: An international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1634\/theoncologist.2018-0266","article-title":"Pancreas cancer-associated weight loss","volume":"24","author":"Hendifar","year":"2019","journal-title":"Oncologist"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Pekarek, L., Fraile-Martinez, O., Garcia-Montero, C., Saez, M.A., Barquero-Pozanco, I., Del Hierro-Marlasca, L., de Castro Martinez, P., Romero-Baz\u00e1n, A., Alvarez-Mon, M.A., and Monserrat, J. (2022). Clinical applications of classical and novel biological markers of pancreatic cancer. Cancers, 14.","DOI":"10.3390\/cancers14081866"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Luo, G., Jin, K., Deng, S., Cheng, H., Fan, Z., Gong, Y., Qian, Y., Huang, Q., Ni, Q., and Liu, C. (2021). Roles of CA19-9 in pancreatic cancer: Biomarker, predictor and promoter. Biochim. Biophys. Acta (BBA) Rev. Cancer, 1875.","DOI":"10.1016\/j.bbcan.2020.188409"},{"key":"ref_17","first-page":"900","article-title":"Lewis antigen-negative pancreatic cancer: An aggressive subgroup","volume":"56","author":"Liu","year":"2020","journal-title":"Int. J. Oncol."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Hou, Y.C., Chen, C.Y., Huang, C.J., Wang, C.J., Chao, Y.J., Chiang, N.J., Wang, H.C., Tung, H.L., Liu, H.C., and Shan, Y.S. (2022). The differential clinical impacts of cachexia and sarcopenia on the prognosis of advanced pancreatic cancer. Cancers, 14.","DOI":"10.3390\/cancers14133137"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/j.clnu.2016.09.008","article-title":"Use of routinely available clinical, nutritional, and functional criteria to classify cachexia in advanced cancer patients","volume":"36","author":"Vigano","year":"2017","journal-title":"Clin. Nutr."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1053\/j.gastro.2022.07.069","article-title":"Nutrient Scavenging From Muscle Cells: A survival strategy of pancreatic cancer cells ends in cachexia","volume":"163","author":"Regel","year":"2022","journal-title":"Gastroenterology"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Ahmad, S.S., Ahmad, K., Shaikh, S., You, H.J., Lee, E.Y., Ali, S., Lee, E.J., and Choi, I. (2022). Molecular mechanisms and current treatment options for cancer cachexia. Cancers, 14.","DOI":"10.3390\/cancers14092107"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"95","DOI":"10.4240\/wjgs.v10.i9.95","article-title":"Molecular therapeutic strategies targeting pancreatic cancer induced cachexia","volume":"10","author":"Yakovenko","year":"2018","journal-title":"World J. Gastrointest. Surg."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e004638","DOI":"10.1136\/jitc-2022-004638","article-title":"Local and systemic immune profiles of human pancreatic ductal adenocarcinoma revealed by single-cell mass cytometry","volume":"10","author":"Brouwer","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.immuni.2012.03.013","article-title":"The JAK-STAT pathway at twenty","volume":"36","author":"Stark","year":"2012","journal-title":"Immunity"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e202201460","DOI":"10.26508\/lsa.202201460","article-title":"STAT3 in tumor fibroblasts promotes an immunosuppressive microenvironment in pancreatic cancer","volume":"5","author":"Lefler","year":"2022","journal-title":"Life Sci. Alliance"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"11168","DOI":"10.3748\/wjg.v21.i39.11168","article-title":"Prognostic significance of plasma interleukin-6\/-8 in pancreatic cancer patients receiving chemoimmunotherapy","volume":"21","author":"Tsukinaga","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1038\/bjc.2013.174","article-title":"Serum levels of IL-6 and IL-1\u03b2 can predict the efficacy of gemcitabine in patients with advanced pancreatic cancer","volume":"108","author":"Mitsunaga","year":"2013","journal-title":"Br. J. Cancer"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s10522-021-09932-z","article-title":"Sarcopenia versus cancer cachexia: The muscle wasting continuum in healthy and diseased aging","volume":"22","author":"Ferreira","year":"2021","journal-title":"Biogerontology"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Fujiwara, Y., Kobayashi, T., Chayahara, N., Imamura, Y., Toyoda, M., Kiyota, N., Mukohara, T., Nishiumi, S., Azuma, T., and Yoshida, M. (2014). Metabolomics evaluation of serum markers for cachexia and their intra-day variation in patients with advanced pancreatic cancer. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0113259"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"114587","DOI":"10.1016\/j.celrep.2024.114587","article-title":"A molecular pathway for cancer cachexia-induced muscle atrophy revealed at single-nucleus resolution","volume":"43","author":"Zhang","year":"2024","journal-title":"Cell Rep."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"RP93312","DOI":"10.7554\/eLife.93312.2","article-title":"Integrative study of skeletal muscle mitochondrial dysfunction in a murine pancreatic cancer-induced cachexia model","volume":"13","author":"Gicquel","year":"2024","journal-title":"eLife"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/jcsm.12678","article-title":"Phenotypic features of cancer cachexia-related loss of skeletal muscle mass and function: Lessons from human and animal studies","volume":"12","author":"Martin","year":"2021","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Poulia, K.A., Antoniadou, D., Sarantis, P., and Karamouzis, M.V. (2022). Pancreatic cancer prognosis, malnutrition risk, and quality of life: A cross-sectional study. Nutrients, 14.","DOI":"10.3390\/nu14030442"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1038\/s41416-021-01301-4","article-title":"Pancreatic cancer cachexia: Three dimensions of a complex syndrome","volume":"124","author":"Kordes","year":"2021","journal-title":"Br. J. Cancer"},{"key":"ref_35","first-page":"375","article-title":"Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma","volume":"70","author":"Grossberg","year":"2020","journal-title":"CA Cancer J. Clin."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Deng, J., Guo, Y., Du, J., Gu, J., Kong, L., Tao, B., Li, J., and Fu, D. (2022). The intricate crosstalk between insulin and pancreatic ductal adenocarcinoma: A review from clinical to molecular. Front. Cell Dev. Biol., 10.","DOI":"10.3389\/fcell.2022.844028"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/s12276-021-00582-2","article-title":"Pancreatic cancer induces muscle wasting by promoting the release of pancreatic adenocarcinoma upregulated factor","volume":"53","author":"Yoo","year":"2021","journal-title":"Exp. Mol. Med."},{"key":"ref_38","first-page":"1835","article-title":"Pancreatic cancer and supportive care--pancreatic exocrine insufficiency negatively impacts on quality of life","volume":"21","author":"Gooden","year":"2013","journal-title":"Support. Care Cancer"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1097\/MCG.0b013e31829f56e7","article-title":"A prospective assessment of the natural course of the exocrine pancreatic function in patients with a pancreatic head tumor","volume":"48","author":"Sikkens","year":"2014","journal-title":"J. Clin. Gastroenterol."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Gilliland, T.M., Villafane-Ferriol, N., Shah, K.P., Shah, R.M., Tran Cao, H.S., Massarweh, N.N., Silberfein, E.J., Choi, E.A., Hsu, C., and McElhany, A.L. (2017). Nutritional and metabolic derangements in pancreatic cancer and pancreatic resection. Nutrients, 9.","DOI":"10.3390\/nu9030243"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/MCG.0000000000001164","article-title":"Practical Perspectives in the Treatment of Nausea and Vomiting","volume":"53","author":"Cangemi","year":"2019","journal-title":"J. Clin. Gastroenterol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1002\/ijc.23114","article-title":"Cannabinoids in pancreatic cancer: Correlation with survival and pain","volume":"122","author":"Michalski","year":"2008","journal-title":"Int. J. Cancer"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/pancan.2018.0019","article-title":"Potential use of cannabinoids for the treatment of pancreatic cancer","volume":"5","author":"Sharafi","year":"2019","journal-title":"J. Pancreat. Cancer"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"e1373","DOI":"10.7717\/peerj.1373","article-title":"Characterization of the salivary microbiome in patients with pancreatic cancer","volume":"3","author":"Torres","year":"2015","journal-title":"PeerJ"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1158\/2159-8290.CD-17-1134","article-title":"The pancreatic cancer microbiome promotes oncogenesis by induction of innate and adaptive immune suppression","volume":"8","author":"Pushalkar","year":"2018","journal-title":"Cancer Discov."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"P\u00f6tgens, S.A., Brossel, H., Sboarina, M., Catry, E., Cani, P.D., Neyrinck, A.M., Delzenne, N.M., and Bindels, L.B. (2018). Klebsiella oxytoca expands in cancer cachexia and acts as a gut pathobiont contributing to intestinal dysfunction. Sci. Rep., 8.","DOI":"10.1038\/s41598-018-30569-5"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Permuth, J.B., Park, M.A., Chen, D.T., Basinski, T., Powers, B.D., Gwede, C.K., Dezsi, K.B., Gomez, M., Vyas, S.L., and Biachi, T. (2024). Leveraging real-world data to predict cancer cachexia stage, quality of life, and survival in a racially and ethnically diverse multi-institutional cohort of treatment-na\u00efve patients with pancreatic ductal adenocarcinoma. Front. Oncol., 14.","DOI":"10.3389\/fonc.2024.1362244"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/cbf.3652","article-title":"Distinct glycolytic pathway regulation in liver, tumour and skeletal muscle of mice with cancer cachexia","volume":"39","author":"Visavadiya","year":"2021","journal-title":"Cell Biochem. Funct."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Wang, F., Liu, H., Hu, L., Liu, Y., Duan, Y., Cui, R., and Tian, W. (2018). The Warburg effect in human pancreatic cancer cells triggers cachexia in athymic mice carrying the cancer cells. BMC Cancer, 18.","DOI":"10.1186\/s12885-018-4271-3"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1097\/00000658-198704000-00005","article-title":"Fatty acid and glycerol kinetics in septic patients and in patients with gastrointestinal cancer. The response to glucose infusion and parenteral feeding","volume":"205","author":"Shaw","year":"1987","journal-title":"Ann. Surg."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"17105","DOI":"10.1038\/nrdp.2017.105","article-title":"Cancer-associated cachexia","volume":"4","author":"Baracos","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1002\/jcsm.13435","article-title":"Phase 2 study of the efficacy and safety of ponsegromab in patients with cancer cachexia: PROACC-1 study design","volume":"15","author":"Groarke","year":"2024","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s12944-017-0495-5","article-title":"Dietary supplementation with n-3-fatty acids in patients with pancreatic cancer and cachexia: Marine phospholipids versus fish oil\u2014A randomized controlled double-blind trial","volume":"16","author":"Werner","year":"2017","journal-title":"Lipids Health Dis."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1007\/BF02446791","article-title":"Comparison of the histochemical and contractile properties of human triceps surae","volume":"30","author":"Moss","year":"1992","journal-title":"Med. Biol. Eng. Comput."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1475-2891-11-52","article-title":"L-Carnitine-supplementation in advanced pancreatic cancer (CARPAN)\u2014A randomized multicentre trial","volume":"11","author":"Kraft","year":"2012","journal-title":"Nutr. J."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Kr\u00fcger, J., Meffert, P.J., Vogt, L.J., G\u00e4rtner, S., Steveling, A., Kraft, M., Mayerle, J., Lerch, M.M., and Aghdassi, A.A. (2016). Early parenteral nutrition in patients with biliopancreatic mass lesions, a prospective, randomized intervention trial. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0166513"},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Pelzer, U., Arnold, D., G\u00f6vercin, M., Stieler, J., Doerken, B., Riess, H., and Oettle, H. (2010). Parenteral nutrition support for patients with pancreatic cancer. Results of a phase II study. BMC Cancer, 10.","DOI":"10.1186\/1471-2407-10-86"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1136\/gut.2004.047563","article-title":"Thalidomide in the treatment of cancer cachexia: A randomised placebo controlled trial","volume":"54","author":"Gordon","year":"2005","journal-title":"Gut"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s11864-020-0707-5","article-title":"Cancer-related fatigue: Causes and current treatment options","volume":"21","author":"Thong","year":"2020","journal-title":"Curr. Treat. Options Oncol."},{"key":"ref_60","first-page":"Cd010804","article-title":"Exercise for cancer cachexia in adults","volume":"3","author":"Grande","year":"2021","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1177\/0964528419873670","article-title":"Differential response to targeted acupuncture by gender in patients with gastrointestinal cancer cachexia: Secondary analysis of a randomized controlled trial","volume":"38","author":"Yoon","year":"2020","journal-title":"Acupunct. Med."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1534735418823269","DOI":"10.1177\/1534735418823269","article-title":"Augmentation of cancer cachexia components with targeted acupuncture in patients with gastrointestinal cancers: A randomized controlled pilot study","volume":"18","author":"Grundmann","year":"2019","journal-title":"Integr. Cancer Ther."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.clnu.2017.05.027","article-title":"Effects of nutrition and physical exercise intervention in palliative cancer patients: A randomized controlled trial","volume":"37","author":"Uster","year":"2018","journal-title":"Clin. Nutr."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"Fso659","DOI":"10.2144\/fsoa-2020-0165","article-title":"Multidisciplinary lifestyle intervention to manage pancreatic cancer-related cachexia: A case report","volume":"7","author":"Avancini","year":"2020","journal-title":"Future Sci. OA"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.clnu.2016.07.015","article-title":"ESPEN guidelines on nutrition in cancer patients","volume":"36","author":"Arends","year":"2017","journal-title":"Clin. Nutr."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1249\/MSS.0000000000002116","article-title":"Exercise guidelines for cancer survivors: Consensus statement from international multidisciplinary roundtable","volume":"51","author":"Campbell","year":"2019","journal-title":"Med. Sci. Sports Exerc."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.clnu.2003.07.001","article-title":"Weight stabilisation is associated with improved survival duration and quality of life in unresectable pancreatic cancer","volume":"23","author":"Davidson","year":"2004","journal-title":"Clin. Nutr."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/jcsm.12499","article-title":"The relationship between the BMI-adjusted weight loss grading system and quality of life in patients with incurable cancer","volume":"11","author":"Daly","year":"2020","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/j.clnu.2016.02.016","article-title":"Skeletal muscle fiber size and fiber type distribution in human cancer: Effects of weight loss and relationship to physical function","volume":"35","author":"Toth","year":"2016","journal-title":"Clin. Nutr."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1158\/1538-7445.AM2024-382","article-title":"Abstract 382: Pancreatic cancer-derived organoids alter muscle fiber type and increased energy consumption leading to cachexia","volume":"84","author":"Han","year":"2024","journal-title":"Cancer Res."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Youn, S.E., Jiang, F., Won, H.Y., Hong, D.E., Kang, T.H., Park, Y.Y., and Koh, S.S. (2022). PAUF Induces migration of human pancreatic cancer cells exclusively via the TLR4\/MyD88\/NF-\u03baB signaling pathway. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms231911414"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.4049\/jimmunol.1301261","article-title":"Differential regulation of TLR-dependent MyD88 and TRIF signaling pathways by free zinc ions","volume":"191","author":"Brieger","year":"2013","journal-title":"J. Immunol."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Feuerecker, B., Biechl, P., Veltkamp, C., Saur, D., and Eisenreich, W. (2021). Metabolic response of pancreatic carcinoma cells under treatment with dichloroacetate. Metabolites, 11.","DOI":"10.3390\/metabo11060350"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/sj.bjc.6603301","article-title":"A multicenter phase III trial comparing irinotecan-gemcitabine (IG) with gemcitabine (G) monotherapy as first-line treatment in patients with locally advanced or metastatic pancreatic cancer","volume":"95","author":"Stathopoulos","year":"2006","journal-title":"Br. J. Cancer"},{"key":"ref_75","first-page":"5","article-title":"First-line treatment for advanced pancreatic cancer","volume":"12","author":"Oberstein","year":"2011","journal-title":"JOP J. Pancreas"},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Cortez, N.E., Pathak, S., Rodriguez Lanzi, C., Hong, B.V., Crone, R., Sule, R., Wang, F., Chen, S., Gomes, A.V., and Baar, K. (2023). A ketogenic diet in combination with gemcitabine mitigates pancreatic cancer-associated cachexia in male and female KPC mice. Int. J. Mol. Sci., 24.","DOI":"10.20944\/preprints202306.0482.v1"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1080\/01635581.2020.1871495","article-title":"Randomized Phase II study of gemcitabine monotherapy vs. gemcitabine with an EPA-enriched oral supplement in advanced pancreatic cancer","volume":"74","author":"Ueno","year":"2022","journal-title":"Nutr. Cancer"},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Mitchell, T., Clarke, L., Goldberg, A., and Bishop, K.S. (2019). Pancreatic cancer cachexia: The role of nutritional interventions. Healthcare, 7.","DOI":"10.3390\/healthcare7030089"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1158\/0008-5472.277.65.1","article-title":"Attenuation of proteasome-induced proteolysis in skeletal muscle by {beta}-hydroxy-{beta}-methylbutyrate in cancer-induced muscle loss","volume":"65","author":"Smith","year":"2005","journal-title":"Cancer Res."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.biopha.2017.01.071","article-title":"Nanotechnology for delivery of gemcitabine to treat pancreatic cancer","volume":"88","author":"Birhanu","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1056\/NEJMoa1304369","article-title":"Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine","volume":"369","author":"Ervin","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"215969","DOI":"10.1016\/j.canlet.2022.215969","article-title":"Drug conjugate-based anticancer therapy\u2014Current status and perspectives","volume":"552","author":"Yang","year":"2023","journal-title":"Cancer Lett."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1208\/s12249-014-0113-z","article-title":"Polymeric micelles: Nanocarriers for cancer-targeted drug delivery","volume":"15","author":"Zhang","year":"2014","journal-title":"AAPS PharmSciTech"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jconrel.2010.02.021","article-title":"Gemcitabine-loaded PEGylated unilamellar liposomes vs GEMZAR: Biodistribution, pharmacokinetic features and in vivo antitumor activity","volume":"144","author":"Paolino","year":"2010","journal-title":"J. Control Release"},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Narasimhan, A., Jengelley, D.H.A., Huot, J.R., Umberger, T.S., Doud, E.H., Mosley, A.L., Wang, M., Zhong, X., Counts, B.R., and Rupert, J.E. (2023). Gemcitabine plus nab-paclitaxel preserves skeletal and cardiac mass and function in a murine model of pancreatic cancer cachexia. bioRxiv.","DOI":"10.1101\/2023.04.15.536434"}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/17\/19\/3064\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T07:38:10Z","timestamp":1758872290000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/17\/19\/3064"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,25]]},"references-count":85,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["nu17193064"],"URL":"https:\/\/doi.org\/10.3390\/nu17193064","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,25]]}}}